Bio Plus Statistics

Total Valuation

Bio Plus has a market cap or net worth of KRW 344.01 billion. The enterprise value is 389.82 billion.

Market Cap	344.01B
Enterprise Value	389.82B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	Dec 29, 2025

Share Statistics

Bio Plus has 61.54 million shares outstanding. The number of shares has increased by 3.75% in one year.

Current Share Class	61.54M
Shares Outstanding	61.54M
Shares Change (YoY)	+3.75%
Shares Change (QoQ)	-23.29%
Owned by Insiders (%)	31.29%
Owned by Institutions (%)	5.91%
Float	41.96M

Valuation Ratios

The trailing PE ratio is 23.51.

PE Ratio	23.51
Forward PE	n/a
PS Ratio	3.55
PB Ratio	1.82
P/TBV Ratio	2.13
P/FCF Ratio	n/a
P/OCF Ratio	18.60
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.26, with an EV/FCF ratio of -8.67.

EV / Earnings	24.29
EV / Sales	4.03
EV / EBITDA	12.26
EV / EBIT	14.10
EV / FCF	-8.67

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.31.

Current Ratio	0.91
Quick Ratio	0.52
Debt / Equity	0.31
Debt / EBITDA	1.85
Debt / FCF	-1.32
Interest Coverage	89.95

Financial Efficiency

Return on equity (ROE) is 12.31% and return on invested capital (ROIC) is 7.69%.

Return on Equity (ROE)	12.31%
Return on Assets (ROA)	6.43%
Return on Invested Capital (ROIC)	7.69%
Return on Capital Employed (ROCE)	13.99%
Revenue Per Employee	658.52M
Profits Per Employee	109.18M
Employee Count	125
Asset Turnover	0.36
Inventory Turnover	2.49

Taxes

Income Tax	-952.56M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.44% in the last 52 weeks. The beta is 0.53, so Bio Plus's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-2.44%
50-Day Moving Average	6,190.60
200-Day Moving Average	6,868.80
Relative Strength Index (RSI)	41.56
Average Volume (20 Days)	353,106

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio Plus had revenue of KRW 96.80 billion and earned 16.05 billion in profits. Earnings per share was 237.82.

Revenue	96.80B
Gross Profit	66.86B
Operating Income	27.86B
Pretax Income	19.91B
Net Income	16.05B
EBITDA	32.01B
EBIT	27.86B
Earnings Per Share (EPS)	237.82

Full Income Statement

Balance Sheet

The company has 31.87 billion in cash and 59.22 billion in debt, giving a net cash position of -27.35 billion or -444.43 per share.

Cash & Cash Equivalents	31.87B
Total Debt	59.22B
Net Cash	-27.35B
Net Cash Per Share	-444.43
Equity (Book Value)	189.07B
Book Value Per Share	2,772.31
Working Capital	-8.49B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.49 billion and capital expenditures -63.43 billion, giving a free cash flow of -44.94 billion.

Operating Cash Flow	18.49B
Capital Expenditures	-63.43B
Free Cash Flow	-44.94B
FCF Per Share	-730.26

Full Cash Flow Statement

Margins

Gross margin is 69.06%, with operating and profit margins of 28.78% and 16.58%.

Gross Margin	69.06%
Operating Margin	28.78%
Pretax Margin	20.57%
Profit Margin	16.58%
EBITDA Margin	33.07%
EBIT Margin	28.78%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.91%.

Dividend Per Share	50.00
Dividend Yield	0.91%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	18.17%
Buyback Yield	-3.75%
Shareholder Yield	-2.84%
Earnings Yield	4.67%
FCF Yield	-13.06%

Dividend Details

Stock Splits

The last stock split was on November 23, 2022. It was a forward split with a ratio of 4.

Last Split Date	Nov 23, 2022
Split Type	Forward
Split Ratio	4

Scores

Bio Plus has an Altman Z-Score of 3.28 and a Piotroski F-Score of 6.

Altman Z-Score	3.28
Piotroski F-Score	6